SCHEMBL7832090

SCHEMBL7832090

[c]1nc2cccnc2n1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 1/20 0.44
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
ATM Q13315 1/20 0.41
TP53 P04637 2/20 0.40
PABPC1 P11940 1/20 0.40
TNF P01375 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
BRD4 O60885 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7835831 0.91 CYP11B1 (0.46) L3MBTL1LMNAPDE4APDE4BPDE4C
SCHEMBL7833447 0.87 TBXA2R (0.44) L3MBTL1LMNAMEN1KMT2AKDM4E
SCHEMBL9695569 0.86 TP53 (0.44) LMNAMEN1KMT2AKDM4ECYP1A2
SCHEMBL7834654 0.85 HTT (0.49) L3MBTL1LMNAMEN1KMT2AKDM4E
SCHEMBL7833661 0.79 PDE10A (0.37) L3MBTL1LMNAPDE4APDE4BPDE4C
SCHEMBL15156835 0.78 CYP1A2 (0.54) LMNAMEN1KMT2ACYP1A2CYP2C19
SCHEMBL356141 0.77 TNF (0.47) L3MBTL1LMNAMEN1KMT2ACYP1A2
SCHEMBL7838399 0.76 LMNA (0.33) LMNAMEN1KMT2AKDM4ECYP2C19
SCHEMBL15654857 0.74 TP53 (0.33) PDE4BMEN1KMT2AKDM4ETP53
SCHEMBL7837631 0.74 KDM4E (0.42) L3MBTL1LMNAPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed